Dr Reddy’s Can Still Go It Alone After Penning Orencia Biosimilar Deal
Clinical Stage Biotech Coya Joins Forces With Reddy’s For Dual Biologic
Targeting a dual biologic for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis, Coya Therapeutics has joined forces with abatacept biosimilar developer Dr Reddy’s.
